This document discusses alternative approaches to treating ADHD without medication. It notes that ADHD is often misdiagnosed and many conditions can cause ADHD-like symptoms. Stimulant medications for ADHD like Ritalin have many potential side effects and may cause long-term brain changes. Lifestyle factors like nutrition, sleep, screen time, and treating underlying conditions provide a safer alternative or addition to medications for managing ADHD symptoms.
ADHD is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. It affects about 5% of children worldwide. The exact causes are unknown but genetics play a role. The symptoms of ADHD can be divided into three presentations - predominantly inattentive, predominantly hyperactive/impulsive, or a combined type. Treatment involves a multidisciplinary approach including behavioral therapy, lifestyle changes, educational support, and often medication. Stimulant medications are most commonly used but have potential side effects so require careful management. With support, many people with ADHD can learn strategies to manage their symptoms and live productive lives.
This document provides an overview of attention deficit hyperactivity disorder (ADHD), including diagnostic criteria, incidence rates, treatment options, and recent Virginia Medicaid data on ADHD diagnoses and medication rates. It begins with the goals of reviewing the ADHD diagnosis, latest treatment algorithms, and Virginia Medicaid data compared to other states and nationally. Diagnostic criteria and symptoms from the DSM-V are outlined. Treatment options discussed include behavioral therapy and FDA-approved medications like stimulants. Virginia Medicaid data on ADHD diagnoses and medication rates among children and adults is presented compared to other state Medicaid plans.
The document provides an overview of Attention Deficit Hyperactivity Disorder (ADHD), including its definition, clinical presentation, diagnosis criteria according to DSM-V, epidemiology, common comorbidities, prognosis, and management approaches. ADHD is defined as a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. It affects about 5-8% of children and 2.5% of adults worldwide, and diagnosis involves evaluating symptoms, impairment, age of onset, and ruling out alternative causes according to DSM-V criteria. Management involves behavioral interventions, stimulant medications, and other pharmacological and non-pharmacological options.
This document provides an overview of Attention Deficit Hyperactivity Disorder (ADHD), including its main symptoms, types, causes, treatments, and preventions. ADHD is a mental illness commonly diagnosed in young people characterized by inattention, hyperactivity, and impulsivity. There are three main types - predominantly inattentive, predominantly hyperactive/impulsive, and a combination of both. While the exact causes are unknown, ADHD tends to be hereditary and may involve chemical imbalances or brain changes. Treatment focuses on medication and therapy to control symptoms, as ADHD cannot be cured. Prevention strategies include avoiding toxins, head injuries, smoking/drinking during pregnancy, and maintaining a healthy diet.
ADHD is a neurodevelopmental disorder characterized by inattention and/or hyperactivity-impulsivity. It affects 5-8% of children and persists into adulthood in approximately 60% of cases. Boys are more likely to be affected than girls. ADHD is diagnosed based on symptoms interfering with functioning in multiple settings. While the exact causes are unknown, genetic factors and executive function deficits play a role. Treatment involves behavioral therapy and stimulant medications, with methylphenidate and dexmethylphenidate being first line medication options.
ADHD is a disorder characterized by inattention, hyperactivity, and impulsivity. The symptoms must be present in more than one setting and interfere with functioning. A diagnosis involves ruling out other potential causes and is based on questionnaires from parents and teachers. Treatment includes medication and behavior therapy with regular follow ups to monitor progress. While the exact causes are unknown, ADHD tends to run in families and is associated with differences in brain development.
ADHD and ADD are disorders characterized by inattention and hyperactivity. ADHD includes symptoms of hyperactivity, impulsivity, and inattentiveness, while ADD primarily involves inattentiveness. Both can be caused by genetic and environmental factors and are most common in children aged 4-17. Treatments include behavior modification, medication, or a combination to reduce symptoms.
ADHD is a neurobehavioral disorder characterized by inattention, hyperactivity, and impulsivity. It is typically diagnosed in childhood and affects daily functioning. Males are more likely to be diagnosed due to differences in symptom presentation between males and females. ADHD is often accompanied by other learning disabilities or mental health issues. Treatment involves medication, therapy, and accommodations to help those with ADHD cope through establishing structure, minimizing distractions, and being understanding of their challenges.
ADHD is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. It affects about 5% of children worldwide. The exact causes are unknown but genetics play a role. The symptoms of ADHD can be divided into three presentations - predominantly inattentive, predominantly hyperactive/impulsive, or a combined type. Treatment involves a multidisciplinary approach including behavioral therapy, lifestyle changes, educational support, and often medication. Stimulant medications are most commonly used but have potential side effects so require careful management. With support, many people with ADHD can learn strategies to manage their symptoms and live productive lives.
This document provides an overview of attention deficit hyperactivity disorder (ADHD), including diagnostic criteria, incidence rates, treatment options, and recent Virginia Medicaid data on ADHD diagnoses and medication rates. It begins with the goals of reviewing the ADHD diagnosis, latest treatment algorithms, and Virginia Medicaid data compared to other states and nationally. Diagnostic criteria and symptoms from the DSM-V are outlined. Treatment options discussed include behavioral therapy and FDA-approved medications like stimulants. Virginia Medicaid data on ADHD diagnoses and medication rates among children and adults is presented compared to other state Medicaid plans.
The document provides an overview of Attention Deficit Hyperactivity Disorder (ADHD), including its definition, clinical presentation, diagnosis criteria according to DSM-V, epidemiology, common comorbidities, prognosis, and management approaches. ADHD is defined as a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. It affects about 5-8% of children and 2.5% of adults worldwide, and diagnosis involves evaluating symptoms, impairment, age of onset, and ruling out alternative causes according to DSM-V criteria. Management involves behavioral interventions, stimulant medications, and other pharmacological and non-pharmacological options.
This document provides an overview of Attention Deficit Hyperactivity Disorder (ADHD), including its main symptoms, types, causes, treatments, and preventions. ADHD is a mental illness commonly diagnosed in young people characterized by inattention, hyperactivity, and impulsivity. There are three main types - predominantly inattentive, predominantly hyperactive/impulsive, and a combination of both. While the exact causes are unknown, ADHD tends to be hereditary and may involve chemical imbalances or brain changes. Treatment focuses on medication and therapy to control symptoms, as ADHD cannot be cured. Prevention strategies include avoiding toxins, head injuries, smoking/drinking during pregnancy, and maintaining a healthy diet.
ADHD is a neurodevelopmental disorder characterized by inattention and/or hyperactivity-impulsivity. It affects 5-8% of children and persists into adulthood in approximately 60% of cases. Boys are more likely to be affected than girls. ADHD is diagnosed based on symptoms interfering with functioning in multiple settings. While the exact causes are unknown, genetic factors and executive function deficits play a role. Treatment involves behavioral therapy and stimulant medications, with methylphenidate and dexmethylphenidate being first line medication options.
ADHD is a disorder characterized by inattention, hyperactivity, and impulsivity. The symptoms must be present in more than one setting and interfere with functioning. A diagnosis involves ruling out other potential causes and is based on questionnaires from parents and teachers. Treatment includes medication and behavior therapy with regular follow ups to monitor progress. While the exact causes are unknown, ADHD tends to run in families and is associated with differences in brain development.
ADHD and ADD are disorders characterized by inattention and hyperactivity. ADHD includes symptoms of hyperactivity, impulsivity, and inattentiveness, while ADD primarily involves inattentiveness. Both can be caused by genetic and environmental factors and are most common in children aged 4-17. Treatments include behavior modification, medication, or a combination to reduce symptoms.
ADHD is a neurobehavioral disorder characterized by inattention, hyperactivity, and impulsivity. It is typically diagnosed in childhood and affects daily functioning. Males are more likely to be diagnosed due to differences in symptom presentation between males and females. ADHD is often accompanied by other learning disabilities or mental health issues. Treatment involves medication, therapy, and accommodations to help those with ADHD cope through establishing structure, minimizing distractions, and being understanding of their challenges.
ADHD is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. It affects 3-7% of school-aged children, with boys being affected 4-9 times more than girls. Genetics play a role in about 75% of cases. Symptoms include difficulty paying attention, hyperactivity, and impulsivity. The first line treatment is stimulant medication along with behavioral therapies to help children develop routines and skills to manage their behavior. Nursing care involves ensuring a safe environment and adequate supervision to prevent injury due to impulsive behaviors.
ADD and ADHD refer to the same condition of attention deficit disorder or attention deficit hyperactive disorder. This condition affects 3-7% of children worldwide and is characterized by low attention, high activity levels, distractibility and impulsivity. The main differences between ADD and ADHD are that ADD is an older term while ADHD specifies three subtypes. Research has implicated four brain regions in the condition - the prefrontal cortex, basal ganglia, cerebellum and corpus callosum. Stimulant medications such as amphetamines and methylphenidate are primarily used to treat the condition by increasing dopamine and norepinephrine levels in the brain. Omega-3 fatty acids have also shown some benefits when coupled
Attention deficit Hyperactivity Disorder (ADHD) (justpsychiatry)Waleed Ahmad
A presentation for undergraduate Education on ADHD. for more, and for original PPTXs, visit:
https://psych.thinkific.com
My question bank:
https://psych.thinkific.com/courses/Psychiatry-question-bank-for-MRCPsych
This document provides an overview of attention-deficit/hyperactivity disorder (ADHD). It discusses that ADHD is a neuropsychiatric condition affecting people worldwide, characterized by diminished sustained attention, increased impulsivity, and hyperactivity. The worldwide prevalence is estimated to be 5.29%. Genetic factors play a large role in its etiology, and treatments include stimulant medications like methylphenidate and non-stimulant medications like atomoxetine. The diagnosis of ADHD is based on criteria from the DSM-5 and involves symptoms of inattention, hyperactivity, and impulsivity interfering with functioning.
ADHD is a developmental disorder affecting 3-6% of children that impacts executive function in the brain. It causes problems with attention span, impulse control, and activity level. The main symptoms are inattention, hyperactivity, and impulsivity. While a real disorder, ADHD is often underestimated and management includes medication, therapy, classroom support, and nutrition.
This document discusses the etiology and treatment of psychiatric disorders in children. It covers prenatal causes like infections, radiation, and nutrition; perinatal causes such as prematurity and birth complications; and postnatal causes including illnesses, injuries, and psychosocial factors. Specific disorders discussed include depression, attention deficit hyperactivity disorder (ADHD), and anxiety disorders. Treatment involves therapy, medication, and addressing environmental stressors through family support and education programs. The causes of these disorders are thought to involve genetic, biological, and environmental factors interacting together.
Since 1996 Dr. Paul Ebben has worked as a neuropsychologist in Frankfort, Kentucky. During that time, Dr. Paul Ebben has conducted a number of psychological examinations including those for the assessment for attention deficit hyperactivity disorder (ADHD).
ADHD is a common neurodevelopmental disorder in children characterized by inattention, hyperactivity, and impulsivity. It affects approximately 9% of school-aged children worldwide. The exact causes are unknown but risk factors include genetic predisposition and complications during pregnancy or birth. Diagnosis involves ruling out other potential causes through clinical evaluation, history, physical exam, and behavior rating scales to assess the severity and impacts of symptoms. Effective treatment options include behavioral therapy and medications.
Attention Deficit Disorder with Hyperactivity (ADHD)ishamagar
This document discusses attention deficit disorder (ADD), including its four types and their characteristics. It provides details on symptoms, causes, diagnosis criteria, and treatment approaches for ADD with hyperactivity (ADHD). Key information includes that ADHD is one of the most common childhood disorders, affecting 3-5% of school-aged children. It involves inattention, hyperactivity, and impulsivity. Treatment may involve behavioral therapy, pharmacological therapy with stimulants or non-stimulants, or a combination approach depending on the child's age. Nursing management focuses on ensuring a safe environment and developing a trusting relationship to encourage the child.
This document provides an overview of several topics in child and adolescent psychiatry. It discusses the tiers of child and adolescent mental health services (CAMHS), ranging from primary care providers (Tier 1) to highly specialized services (Tier 4). It also summarizes several common disorders seen in youth, including conduct disorder, oppositional defiant disorder, attention deficit hyperactivity disorder, enuresis, encopresis, learning disabilities, anxiety disorders like separation anxiety disorder and generalized anxiety disorder, and panic disorder. For each topic, it covers characteristics, causes, symptoms, comorbidities, and management approaches.
Hyperkinetic disorder, also known as attention deficit hyperactivity disorder (ADHD), is characterized by inattentive, restless and impulsive behavior. It is caused by both genetic and environmental factors and affects 5-10% of school-aged children. The three main subtypes are inattentive, hyperactive-impulsive, and combined type. Diagnosis involves evaluating symptoms such as inattention, hyperactivity and impulsivity, which must be present before age 7 and impair functioning. Treatment includes behavioral therapy, psychosocial interventions, and medications like stimulants and antidepressants. Comorbid conditions are common and outcomes vary depending on the individual and treatments.
ADHD and Addiction: Diagnosis and ManagementJacob Kagan
Presentation by Jacob Kagan MD on the diagnosis and management of ADHD and Substance Abuse Disorders, including epidemiology and comorbid conditions,
causality and functional impact, potential explanations for the ADHD/SUD association,stimulant treatment and the risk for SUDs, diversion and misuse of stimulant medications, and treatment recommendations. http://jacobkaganmd.com
ADHD is a common neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. It affects approximately 1-7% of school-aged children worldwide, and is more prevalent in boys. While its exact causes are unknown, genetic and environmental factors like low birth weight, maternal substance use, and head injuries may play a role. ADHD is diagnosed when at least six symptoms of inattention and/or hyperactivity-impulsivity are present for over six months, causing impairment across multiple settings like school and home. Stimulant medications and behavioral therapies are effective treatment options, though symptoms often improve with age as the brain develops in late adolescence in many cases.
This document defines mental retardation as significantly below average intellectual functioning and impaired adaptive behaviors that manifest during development. It estimates the prevalence of mental retardation globally and in India. Causes include genetic factors like Down syndrome, metabolic disorders, infections during pregnancy, birth complications, and childhood illnesses. Mental retardation is classified by IQ scores into mild, moderate, severe and profound. Signs and symptoms, diagnosis, treatment including behavioral management and nursing care are discussed. The prognosis has improved with early intervention and mainstream education focusing on developing life skills.
The document describes the Maryland ADHD Program and Attention-Deficit/Hyperactivity Disorder (ADHD). The program's mission is to conduct clinical research on ADHD assessment and treatment, provide evidence-based assessment and treatment to children and families, train clinical psychologists, and educate the community about ADHD. ADHD is defined by inattentive and hyperactive/impulsive symptoms. It affects 6-10% of children and has an annual societal cost of $36-52 billion. Stimulant medications and behavioral interventions like parent training and classroom management are well-established evidence-based treatments for reducing ADHD symptoms.
1. ADHD is a neurobehavioral disorder characterized by inattention, hyperactivity, and impulsivity. It affects about 5-9% of school-aged children in the US.
2. There are three main subtypes of ADHD - inattentive, hyperactive/impulsive, and combined presentation. Symptoms must be present before age 12 and persist for at least 6 months.
3. Effective treatment involves a comprehensive approach including medication management, behavioral therapy, education/academic supports, and lifestyle changes like regular exercise and sleep routines.
ADHD- Controlling The Mental Itch With HomeopathyWelcome Cure LLP
Millions of children below age of 17 suffer from ADHD worldwide. Children with ADHD commonly have problems paying attention or concentrating. If not treated on time it can lead to uncontrollable anger, erratic and anti-social conduct that tends to strain relationships with parents, siblings and peers. Babies with very low birth weight have an increased risk of developing ADHD. Homeopathy reduces the aggressiveness, restlessness and obstinacy of the child. Homeopathy promotes a happy, constructive, productive, creative development of the child. You can find more of such informative Power Point Presentations as well as other useful health information at www.welcomecure.com, the definitive online homeopathic treatment portal.
www.welcomecure.com
The document discusses attention deficit hyperactivity disorder (ADHD), including:
1. It provides statistics on the prevalence of ADHD in school-aged children and discusses different diagnoses under the DSM-IV criteria.
2. It discusses the neurological basis of ADHD and how stimulant medications like Ritalin work to improve symptoms by affecting neurotransmitters in the brain.
3. It outlines challenges children with ADHD face and emphasizes the importance of a multimodal treatment approach including medication, behavioral management, and academic support.
This document discusses mental health and common mental health conditions. It defines mental health as a state of well-being and the absence of mental disorders. Common mental health conditions include substance dependence, schizophrenia, depressive disorders, bipolar disorder, anxiety disorders, and obsessive-compulsive disorder. Childhood disorders and other conditions are also mentioned. The document also covers the prevalence, symptoms, causes, barriers to treatment, and the current status of mental healthcare in India.
This document discusses managing ADHD through dietary and nutritional support. It provides information on an upcoming event with Dr. Zoltan Rona who will discuss how conditions like vitamin deficiencies, toxicity, and gut issues can be linked to ADHD and learning disabilities. The event will cover orthomolecular medicine approaches for treating ADHD without drugs.
ADHD is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. It affects 3-7% of school-aged children, with boys being affected 4-9 times more than girls. Genetics play a role in about 75% of cases. Symptoms include difficulty paying attention, hyperactivity, and impulsivity. The first line treatment is stimulant medication along with behavioral therapies to help children develop routines and skills to manage their behavior. Nursing care involves ensuring a safe environment and adequate supervision to prevent injury due to impulsive behaviors.
ADD and ADHD refer to the same condition of attention deficit disorder or attention deficit hyperactive disorder. This condition affects 3-7% of children worldwide and is characterized by low attention, high activity levels, distractibility and impulsivity. The main differences between ADD and ADHD are that ADD is an older term while ADHD specifies three subtypes. Research has implicated four brain regions in the condition - the prefrontal cortex, basal ganglia, cerebellum and corpus callosum. Stimulant medications such as amphetamines and methylphenidate are primarily used to treat the condition by increasing dopamine and norepinephrine levels in the brain. Omega-3 fatty acids have also shown some benefits when coupled
Attention deficit Hyperactivity Disorder (ADHD) (justpsychiatry)Waleed Ahmad
A presentation for undergraduate Education on ADHD. for more, and for original PPTXs, visit:
https://psych.thinkific.com
My question bank:
https://psych.thinkific.com/courses/Psychiatry-question-bank-for-MRCPsych
This document provides an overview of attention-deficit/hyperactivity disorder (ADHD). It discusses that ADHD is a neuropsychiatric condition affecting people worldwide, characterized by diminished sustained attention, increased impulsivity, and hyperactivity. The worldwide prevalence is estimated to be 5.29%. Genetic factors play a large role in its etiology, and treatments include stimulant medications like methylphenidate and non-stimulant medications like atomoxetine. The diagnosis of ADHD is based on criteria from the DSM-5 and involves symptoms of inattention, hyperactivity, and impulsivity interfering with functioning.
ADHD is a developmental disorder affecting 3-6% of children that impacts executive function in the brain. It causes problems with attention span, impulse control, and activity level. The main symptoms are inattention, hyperactivity, and impulsivity. While a real disorder, ADHD is often underestimated and management includes medication, therapy, classroom support, and nutrition.
This document discusses the etiology and treatment of psychiatric disorders in children. It covers prenatal causes like infections, radiation, and nutrition; perinatal causes such as prematurity and birth complications; and postnatal causes including illnesses, injuries, and psychosocial factors. Specific disorders discussed include depression, attention deficit hyperactivity disorder (ADHD), and anxiety disorders. Treatment involves therapy, medication, and addressing environmental stressors through family support and education programs. The causes of these disorders are thought to involve genetic, biological, and environmental factors interacting together.
Since 1996 Dr. Paul Ebben has worked as a neuropsychologist in Frankfort, Kentucky. During that time, Dr. Paul Ebben has conducted a number of psychological examinations including those for the assessment for attention deficit hyperactivity disorder (ADHD).
ADHD is a common neurodevelopmental disorder in children characterized by inattention, hyperactivity, and impulsivity. It affects approximately 9% of school-aged children worldwide. The exact causes are unknown but risk factors include genetic predisposition and complications during pregnancy or birth. Diagnosis involves ruling out other potential causes through clinical evaluation, history, physical exam, and behavior rating scales to assess the severity and impacts of symptoms. Effective treatment options include behavioral therapy and medications.
Attention Deficit Disorder with Hyperactivity (ADHD)ishamagar
This document discusses attention deficit disorder (ADD), including its four types and their characteristics. It provides details on symptoms, causes, diagnosis criteria, and treatment approaches for ADD with hyperactivity (ADHD). Key information includes that ADHD is one of the most common childhood disorders, affecting 3-5% of school-aged children. It involves inattention, hyperactivity, and impulsivity. Treatment may involve behavioral therapy, pharmacological therapy with stimulants or non-stimulants, or a combination approach depending on the child's age. Nursing management focuses on ensuring a safe environment and developing a trusting relationship to encourage the child.
This document provides an overview of several topics in child and adolescent psychiatry. It discusses the tiers of child and adolescent mental health services (CAMHS), ranging from primary care providers (Tier 1) to highly specialized services (Tier 4). It also summarizes several common disorders seen in youth, including conduct disorder, oppositional defiant disorder, attention deficit hyperactivity disorder, enuresis, encopresis, learning disabilities, anxiety disorders like separation anxiety disorder and generalized anxiety disorder, and panic disorder. For each topic, it covers characteristics, causes, symptoms, comorbidities, and management approaches.
Hyperkinetic disorder, also known as attention deficit hyperactivity disorder (ADHD), is characterized by inattentive, restless and impulsive behavior. It is caused by both genetic and environmental factors and affects 5-10% of school-aged children. The three main subtypes are inattentive, hyperactive-impulsive, and combined type. Diagnosis involves evaluating symptoms such as inattention, hyperactivity and impulsivity, which must be present before age 7 and impair functioning. Treatment includes behavioral therapy, psychosocial interventions, and medications like stimulants and antidepressants. Comorbid conditions are common and outcomes vary depending on the individual and treatments.
ADHD and Addiction: Diagnosis and ManagementJacob Kagan
Presentation by Jacob Kagan MD on the diagnosis and management of ADHD and Substance Abuse Disorders, including epidemiology and comorbid conditions,
causality and functional impact, potential explanations for the ADHD/SUD association,stimulant treatment and the risk for SUDs, diversion and misuse of stimulant medications, and treatment recommendations. http://jacobkaganmd.com
ADHD is a common neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. It affects approximately 1-7% of school-aged children worldwide, and is more prevalent in boys. While its exact causes are unknown, genetic and environmental factors like low birth weight, maternal substance use, and head injuries may play a role. ADHD is diagnosed when at least six symptoms of inattention and/or hyperactivity-impulsivity are present for over six months, causing impairment across multiple settings like school and home. Stimulant medications and behavioral therapies are effective treatment options, though symptoms often improve with age as the brain develops in late adolescence in many cases.
This document defines mental retardation as significantly below average intellectual functioning and impaired adaptive behaviors that manifest during development. It estimates the prevalence of mental retardation globally and in India. Causes include genetic factors like Down syndrome, metabolic disorders, infections during pregnancy, birth complications, and childhood illnesses. Mental retardation is classified by IQ scores into mild, moderate, severe and profound. Signs and symptoms, diagnosis, treatment including behavioral management and nursing care are discussed. The prognosis has improved with early intervention and mainstream education focusing on developing life skills.
The document describes the Maryland ADHD Program and Attention-Deficit/Hyperactivity Disorder (ADHD). The program's mission is to conduct clinical research on ADHD assessment and treatment, provide evidence-based assessment and treatment to children and families, train clinical psychologists, and educate the community about ADHD. ADHD is defined by inattentive and hyperactive/impulsive symptoms. It affects 6-10% of children and has an annual societal cost of $36-52 billion. Stimulant medications and behavioral interventions like parent training and classroom management are well-established evidence-based treatments for reducing ADHD symptoms.
1. ADHD is a neurobehavioral disorder characterized by inattention, hyperactivity, and impulsivity. It affects about 5-9% of school-aged children in the US.
2. There are three main subtypes of ADHD - inattentive, hyperactive/impulsive, and combined presentation. Symptoms must be present before age 12 and persist for at least 6 months.
3. Effective treatment involves a comprehensive approach including medication management, behavioral therapy, education/academic supports, and lifestyle changes like regular exercise and sleep routines.
ADHD- Controlling The Mental Itch With HomeopathyWelcome Cure LLP
Millions of children below age of 17 suffer from ADHD worldwide. Children with ADHD commonly have problems paying attention or concentrating. If not treated on time it can lead to uncontrollable anger, erratic and anti-social conduct that tends to strain relationships with parents, siblings and peers. Babies with very low birth weight have an increased risk of developing ADHD. Homeopathy reduces the aggressiveness, restlessness and obstinacy of the child. Homeopathy promotes a happy, constructive, productive, creative development of the child. You can find more of such informative Power Point Presentations as well as other useful health information at www.welcomecure.com, the definitive online homeopathic treatment portal.
www.welcomecure.com
The document discusses attention deficit hyperactivity disorder (ADHD), including:
1. It provides statistics on the prevalence of ADHD in school-aged children and discusses different diagnoses under the DSM-IV criteria.
2. It discusses the neurological basis of ADHD and how stimulant medications like Ritalin work to improve symptoms by affecting neurotransmitters in the brain.
3. It outlines challenges children with ADHD face and emphasizes the importance of a multimodal treatment approach including medication, behavioral management, and academic support.
This document discusses mental health and common mental health conditions. It defines mental health as a state of well-being and the absence of mental disorders. Common mental health conditions include substance dependence, schizophrenia, depressive disorders, bipolar disorder, anxiety disorders, and obsessive-compulsive disorder. Childhood disorders and other conditions are also mentioned. The document also covers the prevalence, symptoms, causes, barriers to treatment, and the current status of mental healthcare in India.
This document discusses managing ADHD through dietary and nutritional support. It provides information on an upcoming event with Dr. Zoltan Rona who will discuss how conditions like vitamin deficiencies, toxicity, and gut issues can be linked to ADHD and learning disabilities. The event will cover orthomolecular medicine approaches for treating ADHD without drugs.
This document discusses the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adults, focusing on clinical aspects of medication management. It describes how stimulant medications like methylphenidate and amphetamines are the best documented and most effective treatment for ADHD symptoms. Behavioral therapies can also be effective, either alone or in combination with medication. The optimal treatment is medication management combined with behavioral therapy.
This document summarizes common childhood psychiatric disorders presented by doctors in Bangladesh. It discusses:
1. The increasing prevalence of psychiatric disorders in children worldwide and in Bangladesh based on epidemiological studies.
2. Common disorders seen in Bangladeshi children including anxiety disorders, ADHD, autism spectrum disorders, somatic symptom disorder, and elimination disorders.
3. The causes of rising psychiatric disorders in children such as modern life stresses, technology overuse, and family changes. Treatment approaches including behavioral therapy and pharmacotherapy are mentioned.
This Pecha Kucha presentation defines depression as a mental disorder characterized by low mood, low self-esteem, and loss of interest. It notes that depression is one of the most common mental disorders, affecting about 1 in 4 Canadians at some point in their life. The presentation outlines various signs and symptoms of depression in adults, children, and the elderly. It discusses biological, psychological, and social causes of depression and notes that nearly 2/3 of cases are untreated due to a lack of recognition, social stigma, or disabling symptoms. The presentation concludes by covering treatment options such as counseling, medication, and electroconvulsive therapy, and provides resources for support.
Presented by: Michael R. Peterson MA LAMFT
Executive Director
Steve M. Wickelgren MA MFT
President
Minnesota CIT Officers Association
Jane Marie Sulzle, RN, CNS, MS
PrairieCare
Zoned, Stoned And Blown - by Louis B. Cady, M.D. and Lisa Seif, LCSW, CADAC02...Louis Cady, MD
This presentation reviews the diagnosis, treatment, and sobriety maintenance of dual diagnosis disorders ( psychiatric disorders coupled with chemical dependency and/or alcoholism), using a synthetic blend of two talented clinicians' experiences, humor, and review of precision diagnosis, treatment formulations, and interventions.
The correct answer is D. All of the above. Twin studies have shown a strong genetic influence for schizophrenia, autism spectrum disorder, and attention deficit hyperactivity disorder. For each of these conditions, if one identical twin has the condition, there is a significantly higher chance that the other identical twin will also have the condition compared to fraternal twins or unrelated individuals. This suggests a genetic component is involved in the etiology of these mental health disorders.
This document summarizes Meaghan Kielley's independent study project on alternative treatments for ADD/ADHD. It provides an overview of ADD/ADHD, statistics on diagnosis and medication use, and potential contributing cultural, environmental, and nutritional factors. The bulk of the document involves interviews with practitioners of herbalism, homeopathy, chiropractic care, nutrition, acupuncture, and Traditional Chinese Medicine who discuss their holistic and complementary approaches to treating ADD/ADHD.
Snack N Yak 3 - Other Mental Health Related Concerns Handout - Snack N Yak 3Sarah Rach
The document discusses several mental health issues that commonly affect college students. It provides statistics and details on eating disorders like anorexia and bulimia, which predominantly impact women. Substance abuse and its effects on individuals and society are reviewed. Post-traumatic stress disorder is explained, including what can cause it and its common signs and symptoms. Self-injury and sexual assault are also covered, outlining their emotional and psychological impacts. Treatment options discussed for various conditions include psychotherapy, medication, support groups, and self-care practices.
The document discusses depression and insomnia, including their epidemiology, assessment, and evidence-based treatments. It notes that depression affects over 350 million people globally and is a leading cause of disability. Common treatments include cognitive behavioral therapy, behavioral activation, mindfulness-based therapies, and various medications. Insomnia impacts up to 35% of some populations and is associated with health risks. Evaluation of insomnia involves assessing sleep patterns and behaviors, while treatments focus on improving sleep hygiene, relaxation, and stimulus control.
This document provides information about drug addiction and treatment. It discusses how addiction is a chronic disease that affects the brain, outlines risk factors for drug abuse, and describes how drugs impact the developing teen brain. The document covers various types of drugs, reasons why people use drugs, signs of drug abuse, and parenting strategies. It emphasizes that addiction is treatable and outlines principles of effective treatment, including the use of medication and behavioral therapies. Relapse is discussed as being common, and recovery is presented as an ongoing process involving improved health and wellness.
The document discusses depression, including its prevalence, symptoms, causes, types, and treatment options. Some key points include:
- Depression affects 10-15% of people with diabetes and 35-45% of heart attack patients.
- Symptoms include persistent sadness, changes in appetite and sleep, loss of energy, poor concentration, and thoughts of death.
- Causes can include genetics, environmental stressors, physical illnesses, and personality traits.
- Types of depression include major depression, bipolar disorder, and dysthymia.
- Treatment involves medication, psychotherapy, or a combination of both. Self-care strategies like diet, sleep, and social support can also help combat depression.
This document provides information on geriatric psychiatry and aging-related mental health issues. It discusses several key topics:
1. Age-related changes in physiological functioning can increase vulnerability over time. Late adulthood begins around age 65 and is characterized by gradual decline in functioning of body systems.
2. Life expectancy has been increasing in India and globally, leading to growth in the elderly population. Common concerns for elderly include retirement, economic insecurity, declining health, and loss of independence.
3. Major mental health disorders in elderly include depression, delirium, and dementia. Late-life depression can present differently than depression in younger populations. Delirium is an acute change in mental status that commonly affects hospital
This is a fascinating and informative introduction to the causes, consequences, diagnosis and treatment of ADHD. It is appropriate for parents, teachers, undergraduate and graduate students.
The document summarizes research on Adverse Childhood Experiences (ACEs), which are potentially traumatic events that occur in childhood (0-17 years) such as abuse, neglect, and household dysfunction. The original ACE Study found that ACEs are common, often occur in clusters, and have strong links to health risks and diseases in adulthood. Individuals with 4 or more ACEs are at greatly increased risk for cancer, heart disease, depression, suicide attempts, drug use, and other negative outcomes. While childhood trauma can disrupt brain development and impact health and behavior, building supportive relationships and teaching coping skills can help mitigate negative impacts and break intergenerational cycles of trauma.
This document discusses various topics related to mental health across the lifespan, including:
- Common mental disorders in children such as ADHD, ODD, and eating disorders
- Mental health issues in adolescence like depression, which affects about 9.5% of U.S. adults
- Disorders in adulthood such as PTSD, dementia, Alzheimer's, and Parkinson's disease
- Stress and strategies for coping with stress throughout adulthood like exercise, diet, sleep, and relaxation techniques
The document discusses various mental disorders and assessments, noting that the "Big Three" mental disorders are dementia, depression, and delirium. It provides true/false questions about the characteristics and treatments of conditions like Alzheimer's disease, Parkinson's disease, anxiety disorders, and schizophrenia. The document also addresses factors to consider in assessing mental health across the adult lifespan and among different ethnic groups.
The document discusses several topics related to abnormalities in brain function associated with aging:
- Delirium, depression, and dementia are identified as key manifestations. Delirium is often unrecognized but can indicate a serious medical condition.
- Depression is the most common psychiatric condition in older adults and can lead to disability, suffering, and increased health risks if left untreated.
- Dementia, specifically Alzheimer's disease, is a chronic, progressive neurological disorder causing impairment in memory, cognition, and daily functioning. It is the most common cause of dementia.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
NVBDCP.pptx Nation vector borne disease control program
Adhd march 2015
1.
2. Source for Natural Health Solutions Search
WELLNESS / HEALTH CONDITIONS / AUTISM, ADD, LEARNING DISORDERS
Email
Share This
Facebook
Article Tools
Print
Smaller Font Size
Larger Font Size
« Back to Previous Page
Autism, ADD, Learning Disorders
KIDS ON DRUGS? – There’s a Better
Approach to ADHD
by Dr. Zoltan P. Rona, MD, M.Sc.
Community About Advertising Rates Archives Contact Us Subscriptions Circulation
ing
l Health
ork
http://vitalitymagazine.com/article/kid
s-on-drugs/
3. ADHD Symptoms
• Inattention
1. Easily distracted
2. Forgetful
3. Loses things
4. Difficulty sustaining
attention
5. Avoid/dislike difficult
tasks
6. Difficulty organizing
7. Careless mistakes
8. Doesn’t listen
9. Difficulty following
instructions
• Hyperactive/Impulsiv
e
1. Fidgety
2. Difficulty staying in seat
3. Runs or climbs
excessively Hyper
feeling
4. Acts on the go/ driven
by a motor
5. Difficulty doing things
quietly
6. Talks excessively
7. Difficulty waiting turn
8. Blurts out answers
9. Interrupts/intrudes
4. Differential Diagnosis
• Vision and hearing problems
• Chronic illness with itch; breathing impairment, e.g.,
sleep apnea; sleep problems
• Developmental or learning problems; language
deficits
• Absence seizures
• Acute change in living situation, grief, family conflict,
recent trauma
• Substance abuse; side effect of medications
• Stress
• FREQUENT CO-MORBIDITIES (Other mood or
anxiety disorder; psychotic disorder; adjustment
disorder) fixing them can solve most of the problem
(next slide)
5. ADHD: Comorbidity
• Learning Disability: 37-50%
• Anxiety: 20 to 33%
• Depression: 10 to 20%
• Bipolar: 63 to 92% of Pediatric BPD also
meets criteria for ADHD
• OCD: 40%
• Conduct Disorder: 20%
• Tourettes/Tics:7%
6. CDC Data & Statistics
• CDC's Summary Health Statistics for U.S.
Children: National Health Interview Survey,
2009 (December 2010; Series 10, Number
247)
• 2.1 million children between the ages of 5 to
11 have ADHD (7.6%)
• 3 million children between the ages of 12 to
17 have ADHD (12.2%)
7. Epidemiology:
• Prevalence: 4-11% in US
• Boys: Girls, 3:1
• Etiology: multifactorial
– Genetic – family history of ADHD,
alcoholism, sociopathy, LD, mood and
anxiety disorders
– Medical (maternal smoking and alcohol
use during pregnancy; gestational
diabetes; head injury; seizures; CNS
infection; OSAS), and
– Environmental risks (lead, CO, Cd, TV)
and protective factors (high IQ, supportive,
structured family environment)
– Cultural – much lower prevalence
estimates in Europe and Japan than US
– many unknowns
8. TV and Attention
• TV viewing accounted for
significant portion of the
variation in ratings of ADHD s/s
(Miller CJ, 2007)
• Frequent television viewing
associated with subsequent
attention and school problems
(Johnson JG, 2007)
• No evidence of bidirectionality
between TV time and
Attention/Learning issues
(Johnson JG, 2007)
9.
10. What’s wrong
with his brain?
• 446 kids with and without ADHD scanned
repeatedly over years
• ADHD kids lag 3 yrs in cortical growth
• ADHD: motor cortex matures earlier
• Brain imaging not clinical tool
• No evidence of abnormality, only delay
Shaw P. National Academy of Science. 2007
11. • One physician, Dr. Michael Anderson of
Canton, Georgia, calls ADHD a “made up”
disorder, “an excuse” for doctors to prescribe
Adderall to treat poor academic performance
in inadequate schools.
• October 16, 2012
13. CDC Data & Statistics
• The prevalence of children 4-17
years of age taking ADHD
medication increased from 4.8% in
2007 to 6.1% in 2011
14.
15. CDC REPORTS ECONOMIC COST
• Using a prevalence rate of 5%, the annual societal
‘‘cost of illness’’ for ADHD is estimated to be
between $36 and $52 billion, in 2005 dollars. It is
estimated to be between $12,005 and $17,458
annually per individual.
• Across 10 countries, it was projected that ADHD
was associated with 143.8 million lost days of
productivity each year. Most of this loss can be
attributed to ADHD and not co-occurring
conditions.
16. Ritalin Use in the United States
Estimated Number of Children Taking
Ritalin
Prescriptions of Ritalin for attention deficit hyperactivity
disorder have quadrupled in a decade
1970 - 150,000
1980 - Between 270,000 and 541,000;
1990 - 900,000,
2003 - 2.5 million
2012 – 6 million
17. Medication Challenges
• Poor response
– Poor response in 35% (no behavioral improvement)
– Side effects >50%: nausea, weight loss, insomnia, tics,
irritability, not himself; arryhthmias, liver dysfunction
– Increase in calls to Poison Control Centers
– Failure to take them; stigma; dependence
– Lack of attention to other aspects of lifestyle that improve overall
health and esteem
• Parents seek other options (30% - 40%)
Chan E. J Dev Beh Ped, 2003
Psychopharm Bull 2008; 41:37-47
Setlick, J Pediatrics 2009; 124: 875-80
18. Many conditions can be Misdiagnosed
as ADHD, including:
• Vitamin and Mineral Deficiencies
• Toxic heavy metal excess
• Thyroid problems
• Food and chemical intolerances/allergies
• Candidiasis
• Leaky gut syndrome & Dysbiosis
19. Albert Einstein
• Did you know that Einstein,
one of the greatest geniuses
of the last century, did not
speak until he was four years old
and did not read until he was
seven. He was described as
mentally slow, unsociable and
adrift in his foolish dreams. He
was expelled from school, and
refused admittance to the Zurich
Polytech Institute.
• Today, he would have been
put on Ritalin/Adderall,
Concerta, Vtvanase, etc..
20. Famous People Who Exhibit ADD Behaviors or
Have Been Diagnosed as ADD
• Hans Christian Anderson, Ann Bancroft, Beethoven, George
Burns, Harry Belafonte, Thomas Carlyle, Andrew Carnegie,
Lewis Carroll, Prince Charles, Agatha Christie, Winston
Churchill, Admiral Richard Byrd, Stephen Hawkins, Mariel
Hemingway, The Wright Brothers, Eddie Rickenbacker, Ernest
Hemingway, Bill Cosby, John Corcoran, Leonardo da Vinci,
Salvador Dali, Dwight D. Eisenhower, Michael Faraday, F. Scott
Fitzgerald, Henry Ford, Benjamin Franklin, Galileo, Danny
Glover, Steven Hawkins, Tracey Gold, John F. Kennedy, Zsa
Zsa Gabor, Micheal Jordan, Robert Kennedy, Jason Kidd, John
Lennon, Abraham Lincoln, Carl Lewis, Mozart, Napoleon
Nasser, Issac Newton, Picasso, Edgar Allan Poe, Ronald
Reagan, Dan Quayle, George C. Scott, John D. Rockefeller,
Eleanor Roosevelt, Babe Ruth, Nolan Ryan, Pete Rose, Charles
Schwab, Steven Spielberg, Sylvester Stallone, Van Gogh,
Robin Williams, Stevie Wonder
21. Why is Ritalin so controversial?
• Ritalin is classified as a Schedule II controlled
substance. This rating is given to prescription
drugs that have the greatest abuse and
dependence potential. Other drugs in this
category are Morphine, Opium, and Cocaine.
• Ritalin is an amphetamine (“Speed”)
All other ADHD drugs are different versions of
SPEED
22. Why is Ritalin so controversial?
• According to the Diagnostic & Statistical Manual of
Mental Disorders and the PDR, the side effects of Ritalin
include:
– Stunting of growth, depression, insomnia, nervousness,
skin rash, anorexia, nausea, dizziness, abdominal pain,
psychosis in chronic usage, blood pressure and pulse
changes, tourette’s syndrome - a permanent and
irreversible condition characterized by body ticks, spasms,
barking sounds, and screaming obscenities.
23. The Side Effects of Ritalin
• Perhaps the best known effect of chronic
stimulant administration is psychosis.
Psychosis has been associated with
chronic use of several stimulants; e.g. d-
and 1-amphetamine methylphenidate
(Ritalin-P), phenmetrazine and cocaine.
• (from “Predicting Dependence Liability of Stimulant and
Depressant Drugs” by Thompson and Unna
24. DRUGS PRESCRIBED FOR ADHD
• Adderall and Adderall XR
• Concerta
• Dexedrine
• Focalin and Focalin XR
• Metadate CD and Metadate ER
• Methylin and Methylin ER
• Ritalin, Ritalin SR, Ritalin L
• Strattera
• Vyvanse
• Daytrana
• Quillivant XR
• http://www.webmd.com/ad d-adhd/guide/adhd-medical-treatment
25. IRREVERSIBLE BRAIN CHANGES
CAUSED BY STIMULANTS
“In animals chronically administered high doses of
amphetamines [the drugs] produce long-lasting depletion
of dopamine, alterations in dopamine uptake sites, and
reduction in serotonergic activity. Methamphetamine in
particular seems capable of inducing damage to
serotonergic fibers...In monkeys the toxic effects of chronic
amphetamine use include damage to cerebral blood
vessels, neuronal loss [brain cell death], and
microhemorrhages.”
Source: The Comprehensive Textbook of Psychiatry, Jerome Jaffe, 1995
26. Stimulant Medications and Side-Effects
• Decreased Appetite
• Trouble Sleeping
• Abdominal Pain
• Headaches
• Tics
• Bizarre Behavior
• Hallucinations (at least 1:100)
• Potential for Addiction -controversial
• Generally, all of these stop when the medication is stopped
• Stunting of growth
27. More Subtle but “Worrisome” Effects
• “He’s just not himself”
• “He’s lost her spark, or her joy”
• “He’s just not the same kid”
• He’s teary, or sad a lot
• He’s not as enthusiastic or creative.
28. ADHD drugs suspected of hurting
Canadian kids (Toronto Star 26/09/12)
• Suspect Drug: Strattera
• Side Effect: Completed Suicide
• This is just one of nearly 600 cases of Canadian
kids suffering serious, sometimes fatal side
effects suspected to have been caused by ADHD
medications in the past 10 years.
• (David Bruser, 2012, The Toronto Star)
29. ADHD drugs suspected of hurting Canadian kids
(Toronto Star 26/09/12)
• Health Canada, which collects these adverse
reaction reports, does not alert the public to
the magnitude of these side effects.
• “It is primarily the (drug company’s)
responsibility to monitor the safe use of their
products,” Health Canada told the Star.
30. ADHD drugs suspected of hurting Canadian kids
(Toronto Star 26/09/12)
• The Star also found four deaths that were not suicides, including an
18-year-old girl who died after a cerebral hemorrhage in 2011.
• The Star found side effects on most parts of the body — the brain,
respiratory system, several major organs, blood, skin, eyes, ears,
and hair, including:
• 20 kids had psychotic disorders
• More than 40 kids suffered depression. A doctor reported a 15-
year-old felt “worthless.” This teen, made aggressive and depressed
by two different, concurrent doses of Adderall XR, hurt himself and
thought about killing himself.
• 24 convulsions, including a 7-year-old on Adderall XR in 2010.
• 48 hallucinations, including 11 cases of kids hearing voices. In the
antiseptic language of adverse-reaction reporting, this side effect
is labelled “auditory hallucination.”
31. ADHD drugs suspected of hurting Canadian kids
(Toronto Star 26/09/12)
• 20 overdoses, eight of those intentional, including a 10-year-old boy
on Ritalin.
• 3 strokes: an 11-year-old boy; a 16-year-old boy; and an 18-year-old
girl also on birth control
• 28 cases of heart problems, including irregular heartbeats, blood
pressure spikes, chest pain and one ventricular fibrillation (severely
abnormal heart rhythm). An 8-year-old girl suffered a heart attack.
• 23 cases involving side effects on the liver, including a 6-year-old
boy on two ADHD drugs with abnormal liver function, and a 12-
year-old who died in 2007 after developing a liver tumour.
• Other side effects experienced by 7-year-olds include sleep terror,
emotional disorder, moaning, convulsion, weight loss, chest pain,
muscle twitching, intentional self-injury, depression, staring and
fecal incontinence.
32. ADHD drugs suspected of hurting Canadian kids
(Toronto Star 26/09/12)
• A long list of very rare but disturbing side effects,
including increased intracranial pressure; muscle
coordination problems that made it difficult for kids to
walk or speak; involuntary and repetitive body
movements; incoherent talkativeness; eyes rolling into
the head; blindness in a 14-year-old girl on two ADHD
drugs; rectal hemorrhage; angina; blisters covering the
body; twisted neck; deafness; face swelling; a tumour
in an 8-year-old girl and growth retardation.
• In each of the 600 reports, the youth either went to
hospital, suffered a disability or life-threatening
condition, or died.
33. Ottawa keeps ADHD reports secret
(Toronto Star September 28, 2012)
• Health Canada has detailed records of probes
into ADHD drug safety, including fatalities,
that it is keeping secret from the public.
• Every six months to a year, drug companies
submit summaries of side effects suspected to
have been caused by their drugs worldwide,
information Health Canada says it evaluates.
• These summaries, called periodic safety
update reports, are not available to the public.
34. ARE THE SIDE EFFECTS WORTH IT?
DO ADHD DRUGS WORK?
• A study by William Frankenberger and
Christine Cannon at the Human
Development Center at the University of
Wisconsin in Eau Claire published in 1999
found that 13 ADHD children on
medication performed progressively worse
over four years on standardized tests
when compared with a group of 13 normal
children with similar IQs and other
characteristics.
35. Links to Ritalin
• Ritalin use is linked to crime and
violence more than any other drug,
according to a Canadian report.
• Well known criminal defense attorney from
Georgia, Melvin Nash, states that between
50-60% of the people he represents for
everything from traffic violations to armed
robbery have been on Ritalin at some
point in their life.
36. QUICK FACTS
There are 7 billion people in the world.
Over 330 million of those live in the US and
Canada
The US and Canada makes up 30% of the total
population.
95% of Ritalin is consumed in the US and Canada.
If ADD is so prevalent, then why does 25% of the
population consume 95% of Ritalin.
The national average for children on Ritalin in
Canada and the US is 5.6%.
37. SCIENCE DAILY
• One in six college students misuse ADHD stimulant drugs
• Getting into trouble with drugs is one way to derail a promising future, and a lot more than
traffickers in hard narcotics are engaging in risky behavior on university campuses. A recent
literature review published by researchers at the University of South One in six college
students misuse ADHD stimulant drugs
• Date:
• March 10, 2015
• Source:
• University of South Carolina
• Summary:
• One in six college students misuse the stimulant drugs prescribed for ADHD, such as Ritalin
and Adderall, considerably more than reported in several of the earlier studies, a meta-
analysis shows. Those students run both legal and health risks in off-prescription use of
ADHD stimulant drugs, which are Schedule II controlled substances.
38.
39. An Integrative Approach
It is important to see the child in the context
of his or her family, friends, school, and
community, and not just as someone with a
set of symptoms one is trying to fix.
Sometimes a change in the home
environment, school or teacher is more
important than any medicine or herb.
40. Food for thought - image from Shutterstock (http://thumb101.shutterstock.com/display_pic_with_logo/501730/132337193/stock-photo-food-for-thought-
132337193.jpg)
With pharmacological approaches both costly in developed nations and largely inaccessible in developing
countries, scientists and public health experts are looking at nutritional approaches to address mental health
issues. Jerome Sarris, from the University of Melbourne (Australia), and colleagues submit that: “Evidence is
steadily growing for the relation between dietary quality (and potential nutritional deficiencies) and mental
health, and for the select use of nutrient-based supplements to address deficiencies, or as monotherapies or
augmentation therapies.” The team submits that in addition to addressing diet quality, there is sufficient
evidence to support the notion of nutrient-based therapies to assist in the management of psychiatric disorders.
Studies show that a number of nutrients associate with brain health, including omega-3s, B vitamins
(particularly folate and B12), choline, iron, zinc, magnesium, S-adenosyl methionine (SAMe), vitamin D, and
amino acids. The study authors urge that: “We advocate recognition of diet and nutrition as central
determinants of both physical and mental health.”
The Importance of Nutrition in Mental
Health
Posted on Feb. 27, 2015, 6 a.m. in Mental Health (/list/news/mental_health/) Diet (/list/news/diet/) Dietary
Supplementation (/list/news/dietary_supplementation/)
VIEW NEWS SOURCE… (HTTP://MEDICALXPRESS.COM/NEWS/2015-01-DIET-NUTRITION-ESSENTIAL-MENTAL-HEALTH.HTML)
41. TYPES OF STRESS/INTERFERENCES TO
THE NERVOUS SYSTEM
Chemicals – Aspartame, Splenda, NutraSweet, smoke,
alcohol, air and water pollution
Other toxins – lead, cadmium, arsenic, mercury, fluoride,
aluminum; excess copper
Foods - sugar, grains, yeast, food allergies or
intolerances
Deficiencies – vitamin D, zinc, iron, omega-3,
magnesium, amino acids
Drugs – antibiotics, amphetamine,. psychiatric drugs
Wifi,
Poor Communication,
Family Dynamics
42. TOXIC HEAVY METALS
• Drinking Water
• Air Pollution
• Tobacco
• Fish and Seafood
• Antiperspirants
• Heavy Traffic
• Pesticides
• Fertilizers
• Medications
• Aluminum Cookware
• Amalgam Fillings
• Old Paint
43. A child may be exposed to lead, mercury, and other
neurotoxic chemicals through any of the following:
• Dental amalgam fillings. Amalgam fillings are made up
of 40% mercury, nickel, cadmium, and copper.
• Paint. Although lead is no longer an ingredient in paint
these days, older buildings may still have paint with
lead.
• Mercury from older vaccines, when a derivative of
mercury was added as a preservative, may be a
problem. Fish are a common source.
• Pesticides, including spray used indoors.
• Common household chemicals like nail polish, acetone,
and perchloroethylene, a chemical used in dry
cleaning.
44. Basic Nutrition – or “When did Pop Tarts
become a breakfast food?”
• Maintaining a normal blood sugar
– Sugar
– Processed Carbohydrates
– Protein
• And the Glycemic Index
45. • Here's what happens: A child eats a breakfast that
has no fat, no protein, and a high glycemic index
— let's say a bagel with fat-free cream cheese. His
blood sugar goes up, but pretty soon it crashes,
which triggers the release of stress hormones like
adrenaline.
• What you're left with, at around 10 a.m., is a kid
with low blood sugar and lots of adrenaline
circulating in his bloodstream.
David Ludwig, M.D., Ph.D., director of the Optimal Weight for
Life program at Children’s Hospital Boston
46. • He's jittery and fidgety and not paying
attention. That's going to look an awful lot
like ADHD to his teacher.
• The possibility exists that in children predisposed to
ADHD, quality of diet may have additional impact.
• David Ludwig, M.D., Ph.D., director of the Optimal Weight
for Life program at Children’s Hospital Boston
47. Weapons of Mass Destruction
High in sugar
Nutrient-depleted
Fiber-depleted
Oxidized fats
Trans fatty acids
Additives
48. Artificial Colors, Flavors,
and Preservatives
• 273 three year olds with hyperactivity
enrolled in DBPC study
• Given a diet free of food coloring and
preservatives, then a daily drink with
colorings and sodium benzoate.
• Significant increases in hyperactivity when
getting the active mixture.
Batteman B. Arch Dis Child. 2004
49. ADHD and Food Allergy
• 19 children responded favorably to a
multiple food elimination diet.
• 16 completed a DBPC Food Challenge.
• Symptoms improved significantly on days
given placebo rather than foods they were
sensitive to (P=0.003)
Boris M. Annals of Allergy, 1994
50. Elimination Diet May Improve ADHD
Symptoms
• February 10, 2011 — In a group of young children
with attention-deficit/hyperactivity disorder
(ADHD), nearly two-thirds who followed a
restricted elimination diet experienced a
significant reduction in ADHD symptoms and
oppositional defiant behavior. Going off the diet
led to relapse.
• Investigators Suggest 'Diet Therapy" Should Be
Considered in All Children With ADHD
• Lancet. 2011;377:446-448, 494-503.
51. ADHD and Food Allergy
• 62/76 children treated with an Oligoantigenic
diet improved.
• 28/62 who improved completed a DBPCFT -
foods thought to provoke symptoms were
reintroduced. Symptoms worse on active foods
than placebo. 48 foods were incriminated.
• Artificial colorants and preservatives were the
most common provoking substances.
Egger J. Lancet. 1985
52. Elimination Diets
• “Feingold hypothesis”
– Children are sensitive to dietary salicylates and
artificially added colors, flavors, and preservatives
– Learning and behavior problems (including ADHD)
can be reduced or eliminated by removing these
substances
53.
54. Elimination Diets
• At least 8 controlled studies have
demonstrated significant
improvement (w/elimination diet)
compared to a placebo condition, or
deterioration after introducing
offending substances
55.
56. ADHD and Food Allergy
• 19 children responded favorably to a multiple food
elimination diet.
• 16 then completed a DBPC Food Challenge.
• Symptoms improved significantly on days given
placebo rather than foods they were sensitive to
(P=0.003)
• Annals of Allergy. 72(5):462-8, 1994 May
57. How do You Test for Food Sensitivities?
• Single Food Elimination
• Multiple Food Elimination
• Allergy Testing – IgE or IgG (Gamma
Dynacare – 905-790-3000)
• ALCAT
• ELISA/Act
• ???/Electrodermal (Interro, Vega, etc.)
69. Whole Grains
• Vitamins
• Minerals
• Essential fatty acids
• Fiber
• Associated with
reduced risk of
diabetes, stroke, and
heart disease, and
increased longevity
70. Beans (legumes)
• Improve blood-glucose
regulation
• Lower serum cholesterol
• Form “complete protein”
when combined with grain
in 1:3 ratio (dry weight)
74. Tomato
• Major food source of
lycopene
• Prevention and possible
treatment of prostate cancer
• Antihypertensive; inhibits
platelet aggregation
75. Spinach
• Increases plasma
antioxidant activity
• May reduce risk of age-
related macular degeneration
• High in oxalate; increases
urinary oxalate excretion
76. Fruit
• High in potassium,
flavonoids, vitamin C, and
other nutrients
• Contains fiber
• Associated with reduced
risk of heart disease, cancer,
stroke, osteoporosis
77. Pigments in M&M’s
• Yellow 5 Lake
• Red 40 Lake
• Blue 1 Lake
• Yellow 6 Lake
• Blue 2 Lake
• Blue #1
• Blue #2
• Red #40
• Yellow #5
• Yellow #6
78. Blueberry
• Anthocyanosides promote
tissue integrity and play a role
in visual function
• A component of blueberry
(proanthocyanidins?) inhibits
binding of uropathogenic E.
coli to cells lining urinary tract
79. Cranberry
• Prevention of UTIs
• Proanthocyanidins inhibit
binding of pathogenic E. coli to
uroepithelial cells
• Natural antibiotic (hippuric acid)
• Urinary acidification
• Eliminates typical
schizophrenic body odor
82. Nuts
• Contain protein, EFAs, fiber,
magnesium, arginine
• Lower serum cholesterol, may
lower blood pressure
• Associated with reduced risk of
cardiovascular disease, diabetes
• Do not appear to cause obesityEat ‘em raw
83. Meat
• Protein, iron and other
minerals, B vitamins, carnitine
• Cholesterol, saturated fat
• High-temperature cooking
produces cholesterol oxides,
AGEs, and carcinogens
• Top of the food chain
84. Fish
• Protein, omega-3 fatty acids,
and other nutrients
• May reduce risk of
cardiovascular disease
• Fish oil beneficial for a wide
range of conditions
• Top of the food chain: source
of mercury and other toxins
85. Milk
• Protein, calcium, vitamin D,
and other nutrients
• Frequently allergenic
• May promote type 1 diabetes
86. Eggs
• High-quality protein;
choline, lutein, other nutrients
• Minimal effect on serum
cholesterol in most individuals
• No increase in risk of heart
disease, except in diabetics
• Scrambling may produce
oxidized cholesterol
87. Aspartame
Symptoms associated with ingestion
include:
Headaches Convulsions
Eye pain Depression
Loss of vision Anxiety
Chest pain Diarrhea
Palpitations Urinary frequency
Joint pain Edema
96. Rationale for Nutrient Therapy
1. Compensation for a deficient diet
2. Increased requirements resulting from
a) disease
b) medications
c) stress and environmental factors
d) biochemical individuality
3. Pharmacological effects
98. Stress depletes magnesium
Various stressors (noise, sleep deprivation, type A
personality) result in magnesium depletion.
Magnesium deficiency aggravates the deleterious effects
of stress (e.g., hypertension, gastric ulceration, myocardial
damage, noise-induced hearing loss).
Artery 1981;9:205-11; J Am Coll Nutr 1985;4:165-72; Am J Otolaryngol 1994;15:26-32; Clin
Cardiol 1997;20:265-8; Magnesium 1986;5:201-10; Magnesium Deficiency. First Eur Congr
Magnesium, Lisbon 1983, (Karger, Basel 1985):24-9.
99. Nutrients and Air Pollution
Vitamins C and E attenuated the
adverse effect of ozone on lung
function of asthmatics.
Arch Environ Health 2001;56:242-9
Am J Respir Crit Care Med 2002;166:703-9
100. Symptoms of Mg deficiency
Fatigue Memory loss
Anxiety Intestinal complaints
Weakness Headaches
Chest pain Lightheadedness
Dyspnea Poor stress tolerance
Muscle cramps Insomnia
Palpitations Lump in throat
101. Omega-3 Fatty Acids
• Omega-3 FA’s are polyunsaturated, meaning they
contain more than one double bond
• They are called omega-3 because the first double
bond counting from the methyl end of the fatty acid
is located at the third carbon atom
103. Alpha-linolenic Acid
• Humans can synthesize other omega-3 fatty acids from ALA:
• Eicosapentaenoic acid (EPA): 20:5n-3
• Docosahexaenoic acid (DHA): 22:6n-3
• These two are usually referred to as marine-derived
omega-3 fatty acids because they are abundant in
certain species of fish
• Whereas, ALA is considered a plant-derived omega-3 fatty
acid
104. Omega-3’s, ADHD, and LD
• 41 Children with ADHD and LD given a Omega-
3’s for 12 weeks or a placebo.
• After 12 weeks, children in the treatment
group had significant improvement in their
ADHD scores compared to placebo.
Progress in Neuro-Psychopharmacology
& Biological Psychiatry (2002)
105. Omega 3 Fat DHA May Benefit Those with
ADHD
• The children, aged 7-12, randomly received the omega 3
fats (EPA and DHA) or safflower oil (omega-6) for a period
of four months. While there were no significant differences
among the groups, the increased amount of omega 3 fats,
in particular DHA, was associated with improved reading
and behavior. Among 17 children with learning disabilities
there were improvements in reading, spelling, behavior,
attention, and hyperactivity.
• The authors of the study conclude that increases in DHA
may improve reading and behavior, especially in those
children who also have learning difficulties.
• Nutrition. 2012 Jun;28(6):670-7
106. Inefficient Conversion of ALA
(Flax Oil) To EPA and DHA
• A possible cause for the low fish oil status
of the ADHD children may be impaired
conversion of the fatty acid precursors LA
and ALA to their longer and more highly
unsaturated products, such as EPA and
DHA (fish oil fats).
107. Inefficient Conversion of ALA
(Flax Oil) To EPA and DHA
• It appears that children with ADHD just
are not able to chemically convert the
plant omega-3, ALA to fish oil very well.
The problem is further worsened when
omega-6 fats are consumed and the ideal
omega-6:3 ratio of 1:1, progresses to the
typical standard American ratio of 15:1.
Many of these children have ratios which
are even worse and can be as high as
50:1.
108. SYMPTOMS SUGGESTING A POSSIBLE
NEED FOR ESSENTIAL FATTY ACIDS
• Dry, flaking skin
• “Chicken skin” or bumps on the outer upper
arms, thighs, or cheeks
• Brittle, soft, or splitting fingernails
• Nails with longitudinal lines
• Dry hair
• Dry scaling in the ear canal
• ADHD, DEPRESSION, ANXIETY
• Eczema
• Asthma
109. Essential fatty acids for
ADHD
• 41 kids, RCT to EPA 186 mg + DHA 480 mg +
GLA 96 mg + cis-linoleic acid 864 vs. placebo mg
daily for 12 weeks; EFA lowered Conners scores.
Richardson. 2002.
• Oxford-Durham RCT of fatty acids suppl’s for
117 children with developmental coordination
disorder: “significant improvements for active
treatment vs placebo were found in reading,
spelling, and behavior over 3 months of treatment
in parallel groups. After the crossover, similar
changes were seen in the placebo-active group.”
Richardson. Pediatrics, 2005
110. Magnesium?
• French study evaluated magnesium and B6 in 52 ADHD
kids and relatives
– 30 / 52 hyperactive children had low ERC-Mg values
– Open label supplementation with 100 mg daily of Mg and B6 for
3-24 weeks
– “In all patients, symptoms of hyperexcitability (physical
aggressivity, instability, scholar attention, hypertony, spasm,
myoclony) were reduced after 1 to 6 months treatment. Other
family members shared similar symptoms, had low ERC-Mg
values, and also responded clinically to increased
Mg(2+)/vitamin B6 intakes. “
– MORE STUDIES NEEDED; May help anxiety
Mousain-Bosc M, Am J Clin Nutr, 2004
111. Flax oil and vitamin C supplements
improve ADHD
• 30 kids with ADHD, compared with 30 normal kids in
clinic in India
• Supplement with 200 mg ALA + 25 mg Vitamin C twice a
day, for 3 months
• All kids had more EFA in RBC cell membranes after 3
months
• ADHD kids had (P<0.01) improvements in total
hyperactivity score, self-control, psychosomatic,
restlessness, inattention, impulsivity, social problems,
learning problems
Joshi K. Prostaglandins Leukot Essent Fatty Acids. 2006
113. Smoking and ADHD
• Research shows that smoking while
pregnant will increase the possibility of
having an ADD child by four times. Ohio
has the highest incidence of mothers
smoking while they are pregnant: 56%.
114. ANTIBIOTICS AND
DEVELOPMENTAL DELAY
A nationwide survey of nearly 700 children between the ages of
1 and 12 years linked developmental delays (DD) in children and
the amount of antibiotics they have taken. According to a report
issued by the Developmental Delay Registry (DDR) in Silver
Spring, MD:
Those who have taken more than 20 cycles of antibiotics in their lifetime
are over 50% more likely to experience developmental delays.
Source: ADVANCE for speech & language pathologists and audiologists, May 1995
115. DIETARY FOODS AND TOXIC
SUBSTANCES TO AVOID
• SUGAR
– One can of soda has 11 tsp. of sugar, which weakens the immune
system by 30%
• CAFFEINE (coffee, tea, soft drinks, energy drinks,
chocolate bars)
– Adversely affects brain chemistry
• COW’S MILK
– FDA allows the residue of up to 60 different antibiotics plus growth
hormones.
– Remember, cow’s milk is for calves!
• HYDROGENATED OILS & TRANS FATTY ACIDS
– Replaces essential fatty acids in cell membranes of your brain, causing
the cells to leak, function poorly or not at all
116. DIETARY FOODS AND TOXIC
SUBSTANCES TO AVOID
• EDTA
– A preservative that causes kidney damage and
calcium imbalances
• MSG
– Preservative found to damage the retina of infant
rats and destroy nerve cells in the hypothalamus of
the brain
• NUTRASWEET (ASPARTAME)
– A very poisonous neurotoxin
117. DIETARY FOODS AND TOXIC
SUBSTANCES TO AVOID
• BHT/BHA
– Preservative - weakens the immune system
• ARTIFICIAL COLORING
– Some are known carcinogens; many create allergic
reactions that affect brain chemistry
• PROPYLENE GLYCOL
– Food additive that is also used to de-ice airplanes
• SODIUM NITRITE
– Used to cure meat, a known carcinogen
118. DIETARY FOODS AND TOXIC
SUBSTANCES TO AVOID
• PESTICIDES
– Buy organic
• ANTIBIOTICS
– Kills healthy intestinal flora and thus weakens the immune system
• OVER THE COUNTER DRUGS
– Aspirin, Tylenol, Advil, etc. - all suppress white blood cells and
therefore weaken the immune system. Causes intestinal bleeding,
kidney and liver damage.
121. HEALTH COMPLAINTS ASSOCIATED
WITH YEAST-RELATED COMPLEX (YRC)
Problems thinking clearly or remembering
Muscle aches
Insomnia
Hyperactivity
Asthma
Recurrent infections of ear, nose, bladder, etc.
122. HEALTH COMPLAINTS ASSOCIATED
WITH YEAST-RELATED COMPLEX (YRC)
• A change in the balance of intestinal flora can
weaken the mucus lining of the intestines.
• Toxins from the yeast can therefore enter the
blood through the damaged intestinal lining,
• affecting the area of the brain that controls
mood and emotion, thus causing depression,
• irritability and many other health problems.
• Source: Is This Your Child? By Dr. Doris Rapp
125. Nutritional Supplements
• Amino Acid Supplementation
– Reportedly low levels of amino acids in ADHD
– Short-term benefit for tryptophan, 5-HTP,
tyrosine, GABA, Theanine or phenyalanine
126. L-Theanine
• Preliminary studies suggest theanine may
indirectly reduce ADHD hyperactivity by
promoting a sense of relaxation and enhancing
the release of dopamine.
• The "Trends in Food Science & Technology"
journal outlines a human study saying theanine
created an increase in alpha waves, which are
brain waves associated with relaxation. This
increase in alpha waves indicates theanine may
help relieve hyperactivity without causing
drowsiness.
127. GABA
• A study which was conducted in Kyorin University
Medical School in Japan used a natural form of
GABA named PharmaGABA .
• There were 60 participants who were given
either 100mg of the GABA supplement or a
placebo after which they administered a math
test.
• Those who were given GABA have provided 20%
more answers in general and got more correct
answers than the placebo group. This result
proved that GABA increases mental ability.
128. MAGNESIUM GLYCINATE
• Magnesium relaxes the mind. The body uses magnesium to
facilitate sending messages throughout our nervous system.
Magnesium is also used to calm the nervous system, which is
doubly important in children with hyperactivity disorders. With the
right amount of magnesium present in the body, children can think
clearer and concentrate better. Magnesium is also a key factor in
the production of serotonin, an important neurotransmitter that
provides a feeling of calm and well-being. Low levels of serotonin
are associated with irritability, moodiness and depression.
• Magnesium relaxes the body. Magnesium is essential for the
relaxation of muscle fibers. Without this essential mineral, spasms
and twitches are a common problem. Magnesium helps muscles in
the body relax and function properly without disturbances. When
the body feels calm, it is easier for hyperactive children to behave
calmly.
129. Nutritional Supplements
• Iron Supplementation
– Open 30-day trial with 17 non-anemic ADHD boys, improvement in
parents Conners’ scores (Sever et al., 1997)
• Zinc supplementation
– Little research
• Magnesium Supplementation
– 50 kids with ADHD and magnesium deficiency; 6 months; significant
decrease in parent and teacher Conners scores
– Magnesium glycinate is best for absorption and limited bowel side
effects
– Magnesium oxide or citrate better for constipation in lieu of ER visits,
enemas and mineral oil
130. Zinc in ADHD
• Zinc levels predict stimulant
response(Arnold, 1990)
• Serum zinc levels low in ADHD
(Bekaroglu, 1996)
• Zinc effective as supplement to stimulant
(Akhondzadeh, 2004)
• Zinc effective in reducing hyperactive and
impulsive behavior (Bilici, 2005)
131. Zinc in ADHD
• RCT of Zinc supplements for 209 7th graders
• Dose: 0, 10 or 20 mg Zinc 5x/wk for 10 Weeks
• Statistical improvement in 20mg group (no
improvement with lower doses)
Study presented at Experimental Biology meeting April 4, 2005 at San Diego, CA by James
Penland, Ph. D.
132.
133. ADHD and Iron Deficiency
• Fifty-three children with ADHD and 27 controls.
• The mean serum ferritin levels, were lower in the
children with ADHD (mean ± SD, 23 ± 13 ng/mL) than
in the controls (mean ± SD, 44 ± 22 ng/mL; P < .001),
• Arch Pediatr Adolesc Med. 2004
134. Iron in ADHD
• Iron plays a key role in dopamine metabolism
• Low ferritin levels associated with more
hyperactivity in ADHD patients (Oner, 2008)
• 84% of ADHD pts had abnormally low ferritin
levels (Konofal et al, Arch. Pediatr. Adolesc. Med. 2004)
• Iron improved Connor’s ratings (Sever, 1997)
• Iron treatment for ADHD reduced ADHD rating
scale and CGI at 12 weeks (Konofal, 2008)
135. Melatonin in ADHD
• RCT in 25 children with ADHD and chronic
sleep onset insomnia; melatonin 5 mg daily
at 6pm vs. placebo
• Melatonin significantly improved sleep
onset; decreased sleep latency and
increased total sleep time
• No change in ADHD behavior over 4
weeks, but all kids kept using it for one year
Smits. J Neurology, Neurosurg, Psychiatry, 1999
136. American ginseng and Ginkgo for
ADHD
• Open trial among 36 children, 3-17 yo
• Panax quinquefolium (200 mg) + Ginkgo biloba
(50 mg) BID X 4 weeks
• Connors parents scale
– 2 weeks: 31% improved on anxious/shy; 67%
improved on psychosomatic
– 4 weeks: 74% improved on Conners’ ADHD
Index
Lyon, et al. J Psychiatry Neurosci, 2001
137. Behavioral Approaches
• Can be effective, with or without medication
• Often history is good year-bad year, good-
year-bad year. Why? Great teachers!
• Kids with ADHD need structure, firm limits,
and lots of positive reinforcement.
• What if an entire school could have that kind
of approach?
139. OTHER TREATMENTS
• Chinese Herbals
– Chinese herbal cocktail compared to methylphenidate
– Significant improvement rates comparable to stimulate
meds, but more improvement on IQ scores and fewer side
effects
– Need placebo-controlled, double-blind studies
• Acupuncture
– Little data on its efficacy
– Loo (1998) found decreases on parent and teacher
Conners
• Noted that kids with most severe ADHD could not comply with tx
140. Sleep and ADHD
• Children with ADHD have much higher rates
of sleep problems, parasomnias, and sleep
disordered breathing.
• Polysomnography in 33 (3-16 yo) with
ADHD: 24% had obstructive sleep apnea;
30% had periodic limb
movements;Compared with ADHD as
whole= more obese
Goroya JS. Pediatric Neurology, 2009
Li S, 2008
Mayes SD, 2008
141. Meditation
• Mental training that can regulate attention
and brain training?
• Research in non-clinical samples has shown
improvements on attentional blink tests
• Rationale for using mindfulness meditation
with ADHD: can impact symptoms of
inattention and impulsivity, associated
neurocognitive deficits of inhibition, and help
with stress, anxiety, and depression
142. Mindful Meditation
• 3 steps:
– bringing attention to an “attentional anchor” (usually a
sensory input such as a breath
– Noting that distraction occurs and letting go of distraction
– Refocusing or reorienting attention back to the
“attentional anchor”
• Pilot Study (Zylowska et al., 2007)
– 8 week mindful meditation group w/ adults & adolescents
– Pre–post improvements in self-reported ADHD symptoms
and test performance on tasks measuring attention and
cognitive inhibition
– Next steps: controlled clinical study
143. Placebo Effects
• Placebo effects well documented in psychiatry
• Parents and teachers tend to evaluate kids
more positively if they think they are medicated
• Parents and teachers tend to attribute positive
changes to medications even when no meds
are given
Waschbusch, DA J Dev Behav Pediatr 2009
144. Further reading on fructose
Gaby AR. Adverse effects
of dietary fructose. Altern
Med Rev 2005;10:294-
306.
Gaby AR. Sucrose and
high-fructose corn syrup.
In Gaby AR. Nutritional
Medicine. Concord NH,
2011.
www.doctorgaby.com.
145. Take Home Message
• We need to be careful not to over- diagnose
ADHD.
• When we do make the diagnosis, I believe we
should seriously consider at least exploring
non-pharmaceutical options which are
certainly safe, and may be effective, before
beginning psychostimulants.